title: [The ISAR-SAFE study].
authors.affiliation: Dipartimento Cardiovascolare, Ospedale Ferrarotto, Università degli Studi di Catania.
authors.forename: Piera
authors.initials: P
authors.lastname: Capranzano
authors.affiliation: Cardiologia Interventistica, U.O. Cardiologia 2, Dipartimento Cardiovascolare, A.O. Ospedale di Circolo di Varese.
authors.forename: Battistina
authors.initials: B
authors.lastname: Castiglioni
mesh_terms: D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control; D000077144:Clopidogrel; D003327:Coronary Disease / Q000188:drug therapy / Q000601:surgery*; D023903:Coronary Restenosis / Q000209:etiology / Q000517:prevention & control; D004334:Drug Administration Schedule; D054855:Drug-Eluting Stents / Q000009:adverse effects; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000209:etiology / Q000517:prevention & control*; D058921:Purinergic P2Y Receptor Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D012107:Research Design; D012306:Risk; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control*; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin